Orhun Demir

Dr. Orhun Demir

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Clinical Practice and Research
Verified
Journal Article
Open access
PDF file
ODOrhun Demir
Orhun Demir
ÖYÖmer Zühtü Yöndem
Ömer Zühtü Yöndem
BYBarış Ecevit Yüksel
Barış Ecevit Yüksel
MDMehmet Doğanay
Mehmet Doğanay
Sepsis is a global health concern and a medical emergency, defined as the systemic immunological response of the body to an infection, which can lead to severe organ dysfunction and death. This understanding has evolved partly due to advancements in our knowledge of its pathophysiology. The aim of this review is to examine recent advancements in sepsis treatment. Accordingly, the authors reviewed the current literature on sepsis, analyzing advancements in its definitions, treatment guidelines, and management strategies. Sepsis can severely impair immune system functionality, leading to distinct subphenotypes of immunosuppression that increase patients’ susceptibility to infections. These subphenotypes exhibit varying clinical features and responses to treatment, underscoring the necessity of understanding immunosuppression for the advancement of personalized treatment strategies. A transformative shift in sepsis management includes the early recognition of at-risk cases and the prompt, effective use of antibiotics, hemodynamic management, source control, and appropriate supportive care. Although current Surviving Sepsis Campaign guidelines recommend early fluid resuscitation, prompt antibiotic therapy, and monitoring lactate clearance, the authors discuss the objections raised by the Infectious Diseases Society of America regarding these recommendations. In conclusion, initial resuscitation is a critical component of managing sepsis and septic shock, significantly impacting patient outcomes. As our understanding of sepsis continues to evolve, ongoing research and discussions surrounding these guidelines remain essential for improving treatment protocols and enhancing patient care. Given the crucial role of the immune response in sepsis pathophysiology, future research on sepsis management will likely focus on anti-inflammatory mechanisms.

1 January 2024 in Case Reports in Critical Care
Verified
Journal Article
Open access
ODOrhun Demir
Orhun Demir
OYOmer Zuhtu Yondem
Omer Zuhtu Yondem
MDMehmet Doganay
Mehmet Doganay
Background: Hidradenitis suppurativa (HS) is a painful relapsing inflammatory disease characterized with subcutaneous nodules, abscesses, tunnels, and deforming scars. We present a case of HS complicated with amyloidosis who was admitted with sepsis and acute renal failure. Case Report: A 53‐year‐old male patient with a history of HS and amyloidosis was accepted to the intensive care unit suffering from acute kidney failure and sepsis symptoms. He was receiving adalimumab during admission. He received hemodialysis and piperacillin–tazobactam antibiotherapy. After 15 days of hospitalization, his sepsis was treated, but he was taken to a routine hemodialysis programme. Conclusion: In the presence of amyloidosis with intervenient infections, the risk of chronic renal failure in HS cases can be kept in mind even if the patient is receiving TNF inhibitors.

30 December 2025 in Anatolian Journal of Emergency Medicine
Verified
Journal Article
Closed access
ODOrhun Demir
Orhun Demir
ADAslı Türkmen Demir
Aslı Türkmen Demir
Aim: This study aims to examine prehospital and hospital factors influencing survival outcomes of out-of-hospital cardiac arrest (OHCA) patients in a developing Emergency Medical Services (EMS) context. Material and Methods: This retrospective cohort study included OHCA patients (≥18 years) from January 1, 2021, to December 31, 2024, at Lokman Hekim University Ankara Hospital. Patients were divided into four groups according to their survival status; those who survived in the emergency department (Group I), those who did not survive in the emergency department (Group II), those who survived in the hospital (Group III), and those who did not survive in the hospital (Group IV). Results: A total of 644 patients were included. The survival rate in the ED was 52.2%, while the overall survival rate was 6.4%. Significant univariate predictors of emergency department (ED) survival included shorter time to return of spontaneous circulation (ROSC), lower initial lactate levels, shockable first arrest rhythm, witnessed arrest, and location of the arrest. Bystander CPR was also strongly associated with ED survival in univariate analysis (p < 0.001), although it did not reach statistical significance in the multivariate model (p = 0.066). In contrast, both shorter time to ROSC (p < 0.001) and lower lactate levels (p < 0.001) remained independent predictors of ED survival in the multivariate regression analysis. Conclusion: Prehospital factors, such as timely CPR and EMS response times, significantly influence OHCA survival rates. While bystander CPR plays a critical role, optimizing EMS response time and reducing prehospital delays are essential for improving outcomes. Further studies are needed to refine EMS protocols and enhance survival prospects in OHCA patients.

19 March 2025 in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
Verified
Journal Article
Open access
PDF file
BYBaris Ecevit Yuksel
Baris Ecevit Yuksel
OYOmer Zuhtu Yondem
Omer Zuhtu Yondem
ODOrhun Demir
Orhun Demir
Introduction Percutaneous dilatational tracheostomy (PDT) is a common procedure in intensive care units (ICUs) for patients requiring prolonged mechanical ventilation. This study aims to evaluate the outcomes of PDT under fiberoptic bronchoscopy guidance, comparing early versus late tracheostomy timing. Materials and Methods This retrospective study analyzed 57 patients who underwent PDT with fiberoptic bronchoscopy guidance. Patient demographics, Glasgow Coma Scale (GCS) scores, APACHE II scores, duration of mechanical ventilation, and complications were assessed. Results Of the 57 patients, 29.8% underwent early tracheostomy, and 70.2% underwent late tracheostomy. No significant differences were found in terms of age, gender, or GCS and APACHE II scores between the two groups. No significant differences in ICU length of stay, mortality, or weaning from ventilator were observed between the groups. The incidence of minor complications were similar between the two groups. Conclusion The study found no significant difference in clinical outcomes between early and late tracheostomy groups. While bronchoscopy enhanced procedural safety, it did not impact complication rates significantly. The timing of PDT should be individualized based on clinical judgment and patient condition. Tracheostomy timing should be tailored to each patient’s condition, and larger studies are needed to define optimal timing guidelines.

8 November 2021 in Turkish Journal of Intensive Care
Verified
Journal Article
Open access
ODOrhun Demir
Orhun Demir
TSTuba Berra Sarıtaş
Tuba Berra Sarıtaş
Amaç: Skorlama sistemleri yaralanma şiddetinin belirlenmesi, triaj yapılması ve epidemiyolojik verilerin oluşturulmasında kullanılabilirler. Çalışmamızın amacı skorlama sistemlerinin performansını değerlendirmektir. Gereç ve Yöntem: Multitravma tanısıyla yoğun bakım ünitesinde (YBÜ) tedavi edilen 130 hasta çalışmaya alındı. Hastaların demografik özellikleri, mekanik ventilasyonda ve YBÜ’de kalış süreleri, mortalite oranları ve skorlama sistemlerinden aldığı puanlar hesaplandı ve kaydedildi. Bulgular: Hastaların yaş grupları ile mortalite arasındaki ilişki incelendiğinde 65 yaş üzeri hastalarda mortalite yüzdesinin (%65,2), 18-65 yaş arası hastalardaki (%36,7) ve 18 yaş altı hastalardaki mortalite yüzdesinden (%23,5) istatistiksel olarak anlamlı bir şekilde daha yüksek olduğu bulundu (p

16 January 2026 in Genel Tıp Dergisi
Verified
Journal Article
Open access
ADAslı Türkmen Demir
Aslı Türkmen Demir
ODOrhun Demir
Orhun Demir
BYBaris Ecevit Yuksel
Baris Ecevit Yuksel
OYOmer Zuhtu Yondem
Omer Zuhtu Yondem
Aim: Acute pulmonary embolism (APE) is one of the major causes of death globally. The condition results from the combined effects of coagulation disorders, vascular damage, and inflammation. Recently, hematological markers such as the systemic immune response index (SIRI), systemic immune-inflammation index (SII) and neutrophil/lymphocyte ratio (NLR) have been identified as potential predictors of worse clinical outcomes, but their role in APE diagnosis remains underexplored.We aimed to investigate the predictive value of these inflammatory biomarkers on APE diagnosis retrospectively.Materials and Methods: 284 adult patients with suspected APE who underwent computed tomography pulmonary angiography imaging at the Emergency Department were evaluated. Patients were divided into APE group and control group. The C-reactive protein, D-dimer levels, complete blood count Wells Score, SIRI, PLR, NLR and SII scores were evaluated.Results: The APE group included 53, and the control group included 231 participants. History of previous pulmonary embolism, dyspnea, chest pain, Wells score, D-dimer, and C-reactive protein levels white blood cell count, neutrophil count, NLR were significantly higher in the APE group. ROC analysis revealed that NLR, Wells Score, SII, SIRI, and D-dimer were found to have predictive value for APE diagnosis. Multivariate analysis showed Wells score as the only influencing factor for APE diagnosis.Conclusions: NLR, SII, and SIRI, combined with Wells Score and D-dimer levels, may improve the diagnostic accuracy of APE. Further prospective cohorts with larger population can determine the accuracy of these parameters on APE diagnosis.